BIOMAT Database Logo BIOMAT Database Logo

More on captopril and measurement of angiotensin-converting enzyme. 1981

S Dux, and J Rosenfeld, and A Yaron, and A Carmel

UI MeSH Term Description Entries
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Dux, and J Rosenfeld, and A Yaron, and A Carmel
[Angiotensin converting enzyme--captopril].
October 1979, Nihon rinsho. Japanese journal of clinical medicine,
S Dux, and J Rosenfeld, and A Yaron, and A Carmel
The measurement of angiotensin-converting enzyme in subjects receiving captopril.
August 1980, The New England journal of medicine,
S Dux, and J Rosenfeld, and A Yaron, and A Carmel
Captopril and enalapril: angiotensin-converting enzyme inhibitors.
January 1987, Journal of the American Veterinary Medical Association,
S Dux, and J Rosenfeld, and A Yaron, and A Carmel
Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
March 1984, Rational drug therapy,
S Dux, and J Rosenfeld, and A Yaron, and A Carmel
The effects of captopril on rat aortic angiotensin-converting enzyme.
January 1982, Journal of cardiovascular pharmacology,
S Dux, and J Rosenfeld, and A Yaron, and A Carmel
Enthalpy of captopril-angiotensin I-converting enzyme binding.
September 1998, FEBS letters,
S Dux, and J Rosenfeld, and A Yaron, and A Carmel
Measurements of angiotensin converting enzyme in captopril-treated patients.
February 1982, Clinica chimica acta; international journal of clinical chemistry,
S Dux, and J Rosenfeld, and A Yaron, and A Carmel
[Synthesis of angiotensin converting enzyme inhibitor, captopril ester derivatives].
January 1988, Yao xue xue bao = Acta pharmaceutica Sinica,
S Dux, and J Rosenfeld, and A Yaron, and A Carmel
Characterization of angiotensin converting enzyme by [3H]captopril binding.
February 1986, Molecular pharmacology,
S Dux, and J Rosenfeld, and A Yaron, and A Carmel
Clinical experience with the angiotensin converting enzyme inhibitor captopril.
January 1982, Clinical and experimental pharmacology & physiology. Supplement,
Copied contents to your clipboard!